This one is doing terrific, and I think its best (that is, worst) days are yet to come.
I think I’ve made my point with these two: retail is, shall we say, having a downturn, not like that which accompanied the financial crisis. I’d say that’s telling.(more…)
Here are four stocks to watch with strong technical momentum fueled by earnings and other news.
Axsome Therapeutics, Inc. (AXSM) gained 39 cents to $19.54 on Tuesday on 1.4 million shares. The biotech company announced Monday that the FDA granted Breakthrough Therapy Designation for its therapy for major depressive disorder. The stock has been a huge climber this year, starting the year under $3. After flagging in the last week, it looks poised to continue the uptrend, with the next target towards the channel top near $24.